COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,031 Articles (22,627 medRxiv, 8,404 bioRxiv)

Most recent first Previous |  Page 2218: Articles 22171-22180  | Next

Genomic epidemiology of the Los Angeles COVID-19 outbreak
Guo, L., Boocock, J., Hilt, E., Chandrasekaran, S., Zhang, Y., Munugala, C., Sathe, L., Alexander, N., Arboleda, V. A., Flint, J., Eskin, E., Luo, C., Yang, S., Garner, O. B., Yin, Y., Bloom, J. S., Kruglyak, L.
10.1101/2020.09.15.20194712 — Posted: 2020-09-18
In the long shadow of our best intentions: model-based assessment of the consequences of school reopening during the COVID-19 pandemic
Johnson, K. E., Stoddard, M., Nolan, R. P., White, D. E., Hochberg, N. S., Chakravarty, A.
10.1101/2020.09.18.20197400 — Posted: 2020-09-18
Detectability of the novel coronavirus (SARS-CoV-2) infection and rates of mortality for COVID-19 in different regions of the Russian Federation
Goldstein, E.
10.1101/2020.09.18.20197194 — Posted: 2020-09-18
Apparent reductions in COVID-19 Case Fatality Rates reflect changes in average age of those testing positive.
Grant, A.
10.1101/2020.09.18.20197160 — Posted: 2020-09-18
Relations between demographic, geographic, and environmental statistics, and the spread of novel coronavirus disease (COVID-19) in Italy
Rovetta, A., Castaldo, L.
10.1101/2020.09.18.20196980 — Posted: 2020-09-18
Physiological Effect of Prone Positioning in Mechanically Ventilated SARS- CoV-2 Infected Patients with Severe ARDS: Preliminary Analysis of an Observational Study
Roy, A., Behera, S., Pande, A., Bhattacharjee, A., Bhattacharyya, A., Baidya, D. K., Anand, R. K., Ray, B. R., Subramaniam, R., Maitra, S.
10.1101/2020.09.16.20195958 — Posted: 2020-09-18
Seroprevalence and seroconversion rates to SARS-CoV-2 in interns, residents, and medical doctors in a University Hospital in Bogota, Colombia
Ariza, B. E., Torres, Y. X., Salgado, D., Cepeda, M., Gomez, C., Castellanos, J. C., Suarez, F., Cuellar, A., Cardozo, C. C., Angel, J., Franco, M. A.
10.1101/2020.09.15.20195313 — Posted: 2020-09-18
SARS-CoV-2 genomes from Oklahoma, USA
Narayanan, S., Ritchey, J. C., Patil, G., Teluguakula, N., More, S., Malayer, J., Saliki, J., Kaul, A., Ramachandran, A.
10.1101/2020.09.15.20195420 — Posted: 2020-09-18
Inexpensive, versatile and open-source methods for SARS-CoV-2 detection
Graham, T. G. W., Dugast-Darzacq, C., Dailey, G. M., Nguyenla, X. H., Van Dis, E., Esbin, M. N., Abidi, A., Stanley, S. A., Darzacq, X., Tjian, R.
10.1101/2020.09.16.20193466 — Posted: 2020-09-18
High-throughput quantitation of SARS-CoV-2 antibodies in a single-dilution homogeneous assay
Kainulainen, M. H., Bergeron, E., Chatterjee, P., Chapman, A. P., Lee, J., Chida, A., Tang, X., Wharton, R. E., Mercer, K. B., Petway, M., Jenks, H. M., Flietstra, T. D., Schuh, A. J., Satheshkumar, P. S., Chaitram, J. M., Owen, S. M., Finn, M. G., Goldstein, J. M., Montgomery, J. M., Spiropoulou, C. F.
10.1101/2020.09.16.20195446 — Posted: 2020-09-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).